These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

841 related articles for article (PubMed ID: 17979650)

  • 1. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and developments in liposome drug delivery systems.
    Lian T; Ho RJ
    J Pharm Sci; 2001 Jun; 90(6):667-80. PubMed ID: 11357170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
    Immordino ML; Dosio F; Cattel L
    Int J Nanomedicine; 2006; 1(3):297-315. PubMed ID: 17717971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.
    Almeida B; Nag OK; Rogers KE; Delehanty JB
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33271886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in development of targeted liposomal therapeutics.
    Sawant RR; Torchilin VP
    AAPS J; 2012 Jun; 14(2):303-15. PubMed ID: 22415612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and simulation of the liposomal model by using a coarse-grained molecular dynamics approach towards drug delivery goals.
    Parchekani J; Allahverdi A; Taghdir M; Naderi-Manesh H
    Sci Rep; 2022 Feb; 12(1):2371. PubMed ID: 35149771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.
    Okamoto Y; Taguchi K; Yamasaki K; Sakuragi M; Kuroda S; Otagiri M
    J Pharm Sci; 2018 Jan; 107(1):436-445. PubMed ID: 28826882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to Address PK-PD Challenges of Conventional Liposome Formulation with Special Reference to Cancer, Alzheimer's, Diabetes, and Glaucoma: An Update on Modified Liposomal Drug Delivery System.
    Kesharwani P; Kumari K; Gururani R; Jain S; Sharma S
    Curr Drug Metab; 2022; 23(9):678-692. PubMed ID: 35692131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome Delivery Systems for Inhalation: A Critical Review Highlighting Formulation Issues and Anticancer Applications.
    Rudokas M; Najlah M; Alhnan MA; Elhissi A
    Med Princ Pract; 2016; 25 Suppl 2(Suppl 2):60-72. PubMed ID: 26938856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future directions of liposome- and immunoliposome-based cancer therapeutics.
    Park JW; Benz CC; Martin FJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential of liposomes as dental drug delivery systems.
    Nguyen S; Hiorth M; Rykke M; Smistad G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):75-83. PubMed ID: 20875853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and disposition of various drug loaded liposomes.
    Qian S; Li C; Zuo Z
    Curr Drug Metab; 2012 May; 13(4):372-95. PubMed ID: 22443534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.
    Joguparthi V; Anderson BD
    J Pharm Sci; 2008 Jan; 97(1):433-54. PubMed ID: 17918731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size dependent variations of phospholipid based vesicular drug carriers in systemic drug activity.
    Mukherjee B; Mondal L; Chakraborty S; Paul P; Choudhury A; Bhattacharya S; Hossain CM
    Curr Pharm Biotechnol; 2015; 16(4):380-91. PubMed ID: 25658382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.
    Wang Y; Grainger DW
    Adv Drug Deliv Rev; 2019; 151-152():56-71. PubMed ID: 30898571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
    Giddam AK; Zaman M; Skwarczynski M; Toth I
    Nanomedicine (Lond); 2012 Dec; 7(12):1877-93. PubMed ID: 23249332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
    Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
    AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.